Pharmsynthez PJSC (MIC:LIFE) Debt-to-Asset : 0.44 (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Pharmsynthez PJSC Debt-to-Asset?

Pharmsynthez PJSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was ₽720.2 Mil. Pharmsynthez PJSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was ₽40.8 Mil. Pharmsynthez PJSC's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was ₽1,715.0 Mil. Pharmsynthez PJSC's debt to asset for the quarter that ended in Jun. 2023 was 0.44.

Pharmsynthez PJSC Debt-to-Asset Historical Data

The historical data trend for Pharmsynthez PJSC's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmsynthez PJSC Debt-to-Asset Chart

Pharmsynthez PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.18

0.30

0.50

0.56

Pharmsynthez PJSC Semi-Annual Data
	Dec11	Jun13	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Asset	Get a 7-Day Free Trial															-	0.50	0.45	0.56	0.44

Competitive Comparison of Pharmsynthez PJSC's Debt-to-Asset

For the Biotechnology subindustry, Pharmsynthez PJSC's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmsynthez PJSC's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmsynthez PJSC's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharmsynthez PJSC's Debt-to-Asset falls into.

Pharmsynthez PJSC Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Pharmsynthez PJSC's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(703.632	+	41.772)	/	1337.921
	=	0.56

Pharmsynthez PJSC's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(720.246	+	40.771)	/	1715.003
	=	0.44

Pharmsynthez PJSC (MIC:LIFE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Pharmsynthez PJSC Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharmsynthez PJSC's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmsynthez PJSC (MIC:LIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmsynthez PJSC (MIC:LIFE) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Engelsa Prospect, St. Petersburg, RUS, 194358

Website

http://en.pharmsynthez.com

Pharmsynthez PJSC is a pharmaceutical company developing new medications, technologies of drugs for organ-specific delivery and innovative methods of manufacture for pharmaceutical ingredients. The company is engaged in the research and development, production and sales of officinal medicines (original OM) and active pharmaceutical ingredients (API).

Pharmsynthez PJSC (MIC:LIFE) Headlines

No Headlines